Nomura Asset Management’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $161M | Buy |
321,187
+1,215
| +0.4% | +$583K | 0.34% | 47 |
|
|
2026
Q1 | $157M | Buy |
319,972
+21,719
| +7% | +$11.8M | 0.41% | 39 |
|
|
2025
Q4 | $173M | Sell |
298,253
-19,726
| -6% | -$11.2M | 0.44% | 32 |
|
|
2025
Q3 | $154M | Sell |
317,979
-906
| -0.3% | -$422K | 0.4% | 42 |
|
|
2025
Q2 | $129M | Sell |
318,885
-32,650
| -9% | -$13.7M | 0.35% | 49 |
|
|
2025
Q1 | $175M | Buy |
351,535
+37,466
| +12% | +$20.3M | 0.54% | 31 |
|
|
2024
Q4 | $163M | Buy |
314,069
+21,403
| +7% | +$11.8M | 0.49% | 30 |
|
|
2024
Q3 | $181M | Buy |
292,666
+10,462
| +4% | +$6.19M | 0.56% | 29 |
|
|
2024
Q2 | $155M | Sell |
282,204
-1,006
| -0.4% | -$576K | 0.53% | 32 |
|
|
2024
Q1 | $165M | Sell |
283,210
-13,059
| -4% | -$7.33M | 0.6% | 25 |
|
|
2023
Q4 | $157M | Sell |
296,269
-19,001
| -6% | -$9.2M | 0.65% | 25 |
|
|
2023
Q3 | $160M | Sell |
315,270
-2,827
| -0.9% | -$1.51M | 0.75% | 19 |
|
|
2023
Q2 | $166M | Buy |
318,097
+33,257
| +12% | +$17.9M | 0.76% | 19 |
|
|
2023
Q1 | $164M | Sell |
284,840
-19,383
| -6% | -$10.9M | 0.86% | 14 |
|
|
2022
Q4 | $168M | Buy |
304,223
+16,055
| +6% | +$8.51M | 0.97% | 12 |
|
|
2022
Q3 | $146M | Buy |
288,168
+29,371
| +11% | +$16.4M | 0.93% | 13 |
|
|
2022
Q2 | $141M | Buy |
258,797
+7,392
| +3% | +$4.07M | 0.88% | 12 |
|
|
2022
Q1 | $148M | Buy |
251,405
+30,256
| +14% | +$17.4M | 0.81% | 17 |
|
|
2021
Q4 | $148M | Buy |
221,149
+76,699
| +53% | +$47.9M | 0.75% | 20 |
|
|
2021
Q3 | $82.5M | Buy |
144,450
+23,916
| +20% | +$13.1M | 0.47% | 44 |
|
|
2021
Q2 | $60.8M | Sell |
120,534
-9,635
| -7% | -$4.55M | 0.35% | 68 |
|
|
2021
Q1 | $59.4M | Sell |
130,169
-85,062
| -40% | -$40.6M | 0.38% | 62 |
|
|
2020
Q4 | $100M | Buy |
215,231
+6,884
| +3% | +$3.23M | 0.67% | 26 |
|
|
2020
Q3 | $92M | Buy |
208,347
+39,217
| +23% | +$16.2M | 0.71% | 26 |
|
|
2020
Q2 | $61.3M | Buy |
169,130
+97,843
| +137% | +$32.8M | 0.52% | 42 |
|
|
2020
Q1 | $20.2M | Buy |
71,287
+4,687
| +7% | +$1.48M | 0.21% | 103 |
|
|
2019
Q4 | $21.6M | Sell |
66,600
-1,102
| -2% | -$334K | 0.19% | 115 |
|
|
2019
Q3 | $19.7M | Buy |
67,702
+4,088
| +6% | +$1.17M | 0.19% | 120 |
|
|
2019
Q2 | $18.7M | Sell |
63,614
-12,501
| -16% | -$3.44M | 0.18% | 119 |
|
|
2019
Q1 | $20.8M | Sell |
76,115
-1,331
| -2% | -$331K | 0.2% | 107 |
|
|
2018
Q4 | $17.3M | Buy |
77,446
+4,196
| +6% | +$984K | 0.19% | 117 |
|
|
2018
Q3 | $17.9M | Buy |
73,250
+1,682
| +2% | +$387K | 0.17% | 118 |
|
|
2018
Q2 | $14.8M | Buy |
71,568
+5,933
| +9% | +$1.26M | 0.15% | 132 |
|
|
2018
Q1 | $13.6M | Buy |
65,635
+2,570
| +4% | +$539K | 0.15% | 131 |
|
|
2017
Q4 | $12M | Buy |
63,065
+12,116
| +24% | +$2.32M | 0.14% | 144 |
|
|
2017
Q3 | $9.64M | Buy |
50,949
+2,605
| +5% | +$472K | 0.12% | 166 |
|
|
2017
Q2 | $8.43M | Buy |
48,344
+595
| +1% | +$99.9K | 0.11% | 185 |
|
|
2017
Q1 | $7.33M | Sell |
47,749
-3,798
| -7% | -$581K | 0.1% | 208 |
|
|
2016
Q4 | $7.28M | Buy |
51,547
+4,115
| +9% | +$607K | 0.13% | 181 |
|
|
2016
Q3 | $7.54M | Buy |
47,432
+770
| +2% | +$119K | 0.14% | 174 |
|
|
2016
Q2 | $6.89M | Buy |
46,662
+530
| +1% | +$78.2K | 0.13% | 185 |
|
|
2016
Q1 | $6.53M | Buy |
46,132
+360
| +0.8% | +$48.2K | 0.12% | 181 |
|
|
2015
Q4 | $6.49M | Buy |
45,772
+330
| +0.7% | +$44K | 0.13% | 184 |
|
|
2015
Q3 | $5.56M | Buy |
45,442
+1,281
| +3% | +$167K | 0.11% | 202 |
|
|
2015
Q2 | $5.73M | Sell |
44,161
-820
| -2% | -$107K | 0.11% | 195 |
|
|
2015
Q1 | $6.04M | Buy |
44,981
+670
| +2% | +$86.4K | 0.11% | 192 |
|
|
2014
Q4 | $5.61M | Sell |
44,311
-70
| -0.2% | -$8.51K | 0.1% | 209 |
|
|
2014
Q3 | $5.4M | Sell |
44,381
-37,312
| -46% | -$4.54M | 0.1% | 214 |
|
|
2014
Q2 | $9.65M | Buy |
81,693
+28,827
| +55% | +$3.39M | 0.18% | 143 |
|
|
2014
Q1 | $6.35M | Sell |
52,866
-31,597
| -37% | -$3.76M | 0.12% | 190 |
|
|
2013
Q4 | $9.4M | Sell |
84,463
-440
| -0.5% | -$43.8K | 0.17% | 142 |
|
|
2013
Q3 | $7.82M | Sell |
84,903
-8,350
| -9% | -$755K | 0.15% | 161 |
|
|
2013
Q2 | $7.89M | Buy |
+93,253
| New | +$7.76M | 0.16% | 150 |
|
Other funds holding TMO
Nomura Asset Management's TMO Position: Q2 2026 in Review
Nomura Asset Management increased its Thermo Fisher Scientific (TMO) stake by 0.38% in Q2 2026, buying an estimated $583K and bringing the position to 321,187 shares worth $161M. The position accounts for 0.34% of the portfolio, ranked #47.
Nomura Asset Management first reported a position in TMO in Q2 2013 and has held it in 53 quarters since. The position peaked at $181M in Q3 2024. 2,602 funds tracked by Wall St. Rank hold TMO as of Q2 2026.
- Nomura Asset Management held 321,187 shares of Thermo Fisher Scientific worth $161M as of Q2 2026.
- Nomura Asset Management bought 1,215 Thermo Fisher Scientific shares in Q2 2026, an estimated $583K.
- Thermo Fisher Scientific made up 0.34% of Nomura Asset Management's portfolio in Q2 2026, its #47 holding.
- Nomura Asset Management first reported a position in Thermo Fisher Scientific in Q2 2013 and has held it in 53 quarters since.
- Nomura Asset Management's Thermo Fisher Scientific position peaked at $181M in Q3 2024.
- 2,602 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.
Based on Nomura Asset Management's 13F filing for Q2 2026, filed 13 Aug 2026.